SONYA HARRIS: Open Payments
NPI 1417416041 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 13 payments from 7 companies in 2025. Trend: 2023 $272 · 2024 $466 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 4 | $261 |
| Neurocrine BioSciences, Inc. | 1 | $119 |
| ABBVIE INC. | 3 | $58 |
| Indivior Inc. | 2 | $39 |
| Lilly USA, LLC | 1 | $28 |
| Supernus Pharmaceuticals, Inc. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $23 |
Products named: Epclusa, INGREZZA, Yeztugo, SUBLOCADE, VRAYLAR, MOUNJARO, Qelbree, GARDASIL 9.
Industry payments across CT — which companies pay providers there.
